Fauna Bio Incorporated
Latest round
- Seed
Last raised
- Sep 2021
Total raised
- $13M
Investors
- 10
About Fauna Bio Incorporated
Founded in 2018 and headquartered in Emeryville, California, Fauna Bio focuses on drug discovery by utilizing genetic data and proprietary technology. The company is co-founded by Ashley Zehnder and Linda Goodman, with Zehnder serving as the CEO.Fauna Bio specializes in drug discovery, utilizing its proprietary platform, Convergence™, to develop therapies targeting natural disease resistance observed in animal models. The company focuses on creating treatments for obesity, metabolic disorders, and muscle preservation by studying physiological adaptations in species like the tenrec and elephant seal. The end users of these therapies include healthcare providers, patients with chronic diseases, and pharmaceutical companies seeking to enhance their drug portfolios.Fauna Bio's revenue generation strategy revolves around partnerships with major pharmaceutical companies, including a significant agreement with Eli Lilly, which involves an upfront payment, equity investment, and potential milestone payments totaling up to USD 494 mn. Their B2B model focuses on strategic collaborations that provide access to their Convergence™ platform for drug target identification, translating into financial agreements based on discovery milestones and resulting product royalties.14 mn, Fauna Bio plans to utilize the capital to expand its computational and research teams, alongside hiring an experienced drug development professional to oversee internal program development and partnerships. The company is working on upcoming products that will enhance its therapeutic capabilities and is looking to expand its reach into new markets, specifically targeting increased operations in North America and Europe by 2023.
Who invested in Fauna Bio Incorporated
10 investors across 2 rounds
See all investors in Fauna Bio Incorporated
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Fauna Bio Incorporated
Who invested in Fauna Bio Incorporated?
Fauna Bio Incorporated has 10 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Fauna Bio Incorporated raised?
Fauna Bio Incorporated has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Fauna Bio Incorporated last raise money?
Fauna Bio Incorporated's most recent round on record is a Seed, in Sep 2021.
What does Fauna Bio Incorporated do?
Founded in 2018 and headquartered in Emeryville, California, Fauna Bio focuses on drug discovery by utilizing genetic data and proprietary technology.
Where is Fauna Bio Incorporated headquartered?
Fauna Bio Incorporated is headquartered in Emeryville, US.
Which VCs invest in companies like Fauna Bio Incorporated?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Fauna Bio Incorporated's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like Fauna Bio Incorporated? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.